Difference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes.
Department of Urology, Netherland Cancer Institute, Amsterdam.
Henk G
HG
van der Poel
Department of Urology, Royal Melbourne Hospital/Peter MacCallum Cancer Centre, Melbourne, Australia.
Roderick C N
RC
van den Bergh
D001706:Biopsy; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D060787:Neoplasm Grading; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000601:surgery; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D057832:Watchful Waiting / Q000379:methods*
D017430:Prostate-Specific Antigen